8 deaths from unknown illness in J&K's Rajouri, Centre sets up experts team

DC Rajouri, Abhishek Sharma, visited Kotranka to assess ground situation in Badhaal village, where seven people, including six children under the age of 14, have died due to the unidentified illness

Hospitals, hospitals in India
A Biosafety level 3 (BSL-3) mobile laboratory has been dispatched to Rajouri to expedite testing and identify the illness, officials said
Press Trust of India Rajouri/Jammu
2 min read Last Updated : Dec 19 2024 | 6:52 AM IST

The death toll from an unknown illness in Jammu and Kashmir's Rajouri district has risen to eight, with another child succumbing to the mysterious disease in a hospital here on Wednesday, prompting authorities to set up a central team of experts to assist in investigating the cases and fatalities in the affected village.

A Biosafety level 3 (BSL-3) mobile laboratory has been dispatched to Rajouri to expedite testing and identify the illness, officials said.  Twelve-year-old Ashfaq Ahmed, son of Mohammad Rafiq, passed away after being hospitalised at the Government Medical College (GMC) Jammu for six days, officials said.

He was earlier referred to Chandigarh for treatment but could not survive, officials said.

Ashfaq's younger siblingsseven-year-old Ishtiyaq and five-year-old Naziadied last Thursday.

With the death of Ashfaq, the number of fatalities in Badhaal village of Kotranka tehsil has reached eight. All the deceased belonged to two families from the same village.

Deputy Commissioner (DC) Rajouri, Abhishek Sharma, visited Kotranka on Monday to assess the ground situation in Badhaal village, where seven people, including six children under the age of 14, have died due to the unidentified illness.

"In response to the incident, a Biosafety Level 3 (BSL-3) mobile laboratory has been sent to Rajouri. Additionally, a central team of experts has been constituted to assist the Union Territory administration in investigating the cases and fatalities," an official spokesperson said.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Jammu and KashmirJammu and Kashmir governmentIndia healthcarechildren

First Published: Dec 19 2024 | 6:51 AM IST

Next Story